Atossa Therapeutics
ATOS
#10735
Rank
S$27.08 M
Marketcap
S$2.71
Share price
4.95%
Change (1 day)
148.31%
Change (1 year)

Operating Margin for Atossa Therapeutics (ATOS)

Operating Margin as of November 2026 (TTM): -293.74%

According to Atossa Therapeutics's latest financial reports and stock price the company's current Operating Margin is -293.74%. At the end of 2015 the company had an Operating Margin of -725,721.67%.

Operating Margin history for Atossa Therapeutics from 2012 to 2015

Operating Margin at the end of each year

Year Operating Margin Change
2015-725,721.67%25940.26%
2014-2,786.92%63.46%
2013-1,704.94%61.72%
2012-1,054.26%-99.54%
2011-229,484.60%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-111.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
12.60%-104.29%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
7.93%-102.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
18.52%-106.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-15.16%-94.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-28.53%-90.29%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.